Latest Posts

Amorepacific India sets up premium division, names Vidushi Goyal Business Head

Amorepacific India has created a dedicated Premium Division for its high-end K-beauty labels Laneige and Sulwhasoo, and appointed Vidushi Goyal as its Business Head.

Goyal will lead both the business and marketing mandate for the two brands in India. The company said her focus will be on building long-term growth momentum and shaping a more India-centric approach for the two names.

The new structure brings India in line with other high-growth, strategic markets in the Amorepacific Group’s global portfolio, a move that reflects the country’s position as a key focus market for future growth. The division will drive integrated online and offline business and marketing strategy for both brands, with the aim of strengthening Amorepacific’s leadership in India’s premium beauty segment.

Commenting on her new role, Vidushi Goyal, Business Head Premium Division, Amorepacific India, said, “The premium beauty segment in India is at an inflexion point, and I’m excited to lead this journey for Laneige and Sulwhasoo. Laneige has already built a loyal Gen Z and millennial following, while Sulwhasoo, with its 80-year heritage in ginseng research, gives us a genuine luxury story to bring to India’s increasingly discerning beauty consumers. I look forward to building both brands into the country’s most-loved K-beauty names, and to strengthening Amorepacific’s leadership in India.”

Goyal brings more than 15 years of experience building and scaling consumer brands across beauty and personal care and direct-to-consumer (D2C). She was part of the founding marketing team at Mamaearth and has also worked on the business side at Swiss Beauty.

Founded in 1932 and officially established in 1945, AmorePacific Corporation is headquartered in Yongsan-gu, Seoul, South Korea. Its portfolio includes Innisfree, Laneige, Sulwhasoo and Etude.

Latest Posts

Don't Miss

Stay in touch

To be updated with all the latest news, offers and special announcements.